This person is not registered. Is this you?

Profile Details
Z Xu

Cleveland Clinic

Institute for Physiological Chemistry
Walter and Eliza Hall Institute of Medical Research

Abramson Cancer Center

AfricaBio Biotechnology Stakeholders Association

University of Melbourne, VIC
Department of Medical Biology

Zhengzhou University

Histology & Pharmacology, Nanjing Medical University
Department of General Surgery

Center for Human Genome Research, Huazhong University of Science and Technology
Department of Epidemiology and Biostatistics and State Key Laboratory of Environment Health

Cancer Center, Qilu Hospital of Shandong University
Department of Urology

The University of Melbourne,
Department of Medical Biology

University of California

China Pharmaceutical University

Zhejiang University
Department of Surgical Oncology

University of Alabama at Birmingham

Jilin University

Johns Hopkins Medicine
Department of Geriatrics

Harbin Medical University
The Department of Thoracic Surgery

Tongji University School of Medicine-Shanghai Pulmonary Hospital

Beihang University

Xiang Ya Nursing School of Central South University
Department of Pathology

Physikdepartment der Technischen Universität München
Department of General Surgery


Cleveland, OH
My Blogs:
My Twitter Hashtags:
[1]School of Humanities and Social Sciences, Beihang University, Beijing 100191, China.
Cancer Biology, Cancer Immunotherapy
Presented at Events Covering:
Areas of Interest:
General Comments:
BSN Rank: 51667 / 2941 (What's this?)
Accomplish Score: 12
Popularity Score: Unavailable
# in My Circle: 0
# in My Org(s): 35635
We'll Post Your CV for Free!
Speaking/Presenting-Abstract/Poster at Mtg: 0 (0 / 0)
Honors and Awards: 0 (0 / 0)
Clinical Trial Activity: 0 (0 / 0)
Grant Support: 0 (0 / 0)
Patents Pending: 0 (0 / 0)
Journal - Editor/Reviewer: 0 (0 / 0)
Peer Reviewed Papers, Books, Chapters: 2 (12 / 0)
  • Purpose The aim of this study was to evaluate the clinical response of immunotherapy with dendritic cell-cytotoxic T lymphocytes (DC-CTLs) in patients with hepatocellular carcinoma (HCC). ()
  • Pancreatic cancer (PC) is one of the most dangerous cancers with less than 5% survival rate in 5 years. ()
Pre/Non Reviewed Papers, Proceedings: 0 (0 / 0)
Membership in Professional Societies: 0 (0 / 0)
White Papers: 0 (0 / 0)
Registered on BiotechScienceNews: 0

3D Tissue Models
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.